BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3079085)

  • 1. A comparison of azathioprine and cyclosporine in liver transplantation: a study of two personal series.
    Krom RA; Wiesner RH; Haagsma EB; Ludwig J; Gips CH; Grond AJ; Houthoff HJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2440-2. PubMed ID: 3079085
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine vs OKT3 prophylaxis after orthotopic liver transplantation.
    Pons JA; Bueno F; Parrilla P; Ramirez P; Bixquert V; Robles R; Miras M; Rodriguez J
    Transplant Proc; 1993 Apr; 25(2):1949. PubMed ID: 8470238
    [No Abstract]   [Full Text] [Related]  

  • 3. Histologic response to OKT3 therapy for hepatic allograft rejection.
    Rohrer RJ; Jenkins RL; Khettry U; Benotti PN; Dodson TF; Karlson CG; Georgi BA; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2459-61. PubMed ID: 3079086
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients.
    Perkins JD; Sterioff S; Wiesner RH; Offord KP; Rakela J; Dickson ER; Krom RA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2434-6. PubMed ID: 3274533
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
    Cherqui D; Duvoux C; Salvat A; Lauzet JY; Metreau JM; Julien M; Fagniez PL; Dhumeaux D
    Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824
    [No Abstract]   [Full Text] [Related]  

  • 6. Transient hyperphosphatasemia after liver transplantation in infancy.
    Lachaux A; Chambon M; Boillot O; Le Gall C; Loras I; Canterino I; Pouillaude JM; Gille D; David L; Hermier M
    Transplant Proc; 1996 Oct; 28(5):2847. PubMed ID: 8908095
    [No Abstract]   [Full Text] [Related]  

  • 7. FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man.
    Söderdahl G; Groth CG; Angelin B; Duraj F; Einarsson K; Ericzon BG
    Transplant Proc; 1995 Feb; 27(1):1125. PubMed ID: 7533362
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion from Sandimmune to Neoral in stable liver graft recipients.
    Pollard SG; Lodge JP
    Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal graft histology in patients treated with different doses of cyclosporine.
    Wilczek HE; Bohman SO; Groth CG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1672-3. PubMed ID: 2652547
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine to azathioprine conversion in cadaveric renal transplants.
    Gonwa TA; Nghiem DD; Corry RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2018-20. PubMed ID: 3079068
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine.
    Park KM; Hay JE; Lee SG; Lee YJ; Wiesner RH; Porayko MK; Krom RA
    Transplant Proc; 1996 Jun; 28(3):1738-40. PubMed ID: 8658863
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled trial of triple therapy in renal transplantation.
    Salaman JR; Griffin PJ; Ross WB; Williams JD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H; Lange H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone repair in cyclosporin treated renal transplant patients.
    Wilmink JM; Bras J; Surachno S; van Heyst JL; van der Horst JM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1492-4. PubMed ID: 2652480
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
    Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
    [No Abstract]   [Full Text] [Related]  

  • 16. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
    Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
    [No Abstract]   [Full Text] [Related]  

  • 17. Results and problems in pediatric liver transplantation in the Cambridge/Kings College Hospital series: 1968 to July 1986.
    Jamieson NV; Calne RY; Rolles K; Barnes ND; Mowat AP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2447-8. PubMed ID: 3274534
    [No Abstract]   [Full Text] [Related]  

  • 18. Histological changes in renal allografts after successful conversion from cyclosporin A to azathioprine.
    Junor BJ; More IA; Bradley JA; Briggs JD; Kyle KF; McGregor E; McMillan MA; Macpherson SG; Van der Merwe W; Rodger RS
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1677-9. PubMed ID: 2652549
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion of long-term renal allograft recipients from prednisolone/azathioprine to cyclosporine monotherapy.
    Birkeland SA; Foged N; Kold AA; Svendsen V; Rohr N; Elbirk A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):171-5. PubMed ID: 3291237
    [No Abstract]   [Full Text] [Related]  

  • 20. The problems associated with conversion from azathioprine and prednisolone to cyclosporine.
    Chapman JR; Taylor HM; Thompson JF; Wood RF; Morris PJ
    Uremia Invest; 1985-1986; 9(1):19-25. PubMed ID: 3915162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.